ArticleCancers2024

Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study.

Ebru Karci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.